Atlanta, GA – Scibility Media – 11/06/2014.
This article discusses two companies: WellCare Health Plans, Inc.(NYSE:WCG) and Celanese Corporation(NYSE:CE)
WellCare Health Plans, Inc.(NYSE:WCG) reported its third quarter 2014 financial results on Nov. 5th, 2014. The figures included a net income of $19.3 million for the period, or $0.44 per diluted share. To contrast, WellCare Health Plans reported a figure of $64 million, or $1.45 per diluted share, for third quarter 2013.
The Florida-based health care plans company provides managed care services for government-sponsored programs in the United States. WellCare offers Medicaid plans, including Temporary Assistance for Needy Families programs. Additionally, the company also provides assistance to low-income families with children. On Oct. 27th, the company announced that it is now serving 102,000 Medicare Advantage members in Florida.
Celanese Corporation(NYSE:CE) announced on Nov. 3rd that it intends to increase the pricing of Fortron PPS by 6% on Jan. 1st, 2015. Alternatively, if the company’s contracts prevent them from rising the price to that height, Celanese intends to adjust the price “as contracts allow.”
The company reported its third quarter 2014 financial results on Oct. 20th, 2014. The figures included an adjusted earnings per share figure of $1.61, a $0.14 increase from the $1.47 mark recorded during the previous quarter.
The Texas-based technology and specialty materials company manufactures and sells a variety of products, including value-added chemicals and thermoplastic polymers. Additionally, its Advanced Engineered Materials segment produces and supplies specialty polymers that are used in medical, electronic, and automotive products.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to firstname.lastname@example.org and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.